Target intelligence / Profile preview

Potassium channel tetramerization domain-containing protein 21 (KCTD21)

Target
KCTD21
Molecular classification
Other, BTB/POZ domain-containing protein, Ubiquitin ligase adaptor
01

Overview

Potassium channel tetramerization domain-containing protein 21 (KCTD21) is a member of the KCTD family, defined by the presence of a BTB/POZ domain at the N-terminus, which is involved in protein-protein interactions and facilitates the formation of multiprotein complexes. KCTD21 is thought to act as a substrate-specific adaptor for a BTB-CUL3-RBX1 E3 ubiquitin ligase complex, mediating the ubiquitination and subsequent proteasomal degradation of specific target proteins, including histone deacetylase 1 (HDAC1). The KCTD21 gene is primarily involved in processes such as the negative regulation of the Smoothened signaling pathway and ubiquitin-dependent protein catabolism. While many KCTD family proteins, including closely related KCTD11, have been implicated in the regulation of signaling pathways relevant to cancer and other diseases, the precise pathological significance and therapeutic potential of KCTD21 itself remain under investigation. There are currently no documented, clinically approved drugs targeting KCTD21, nor well-established safety concerns or biomarker roles described in the literature.

Other names
BTB/POZ domain-containing protein KCTD21KCASH2KCASH2 proteinpotassium channel tetramerization domain containing 21
02

Biological functions

Ubiquitin-dependent protein catabolic processNegative regulation of Smoothened signaling pathwayHistone deacetylase bindingCullin family protein bindingIdentical protein binding
03

Disease associations

Cancer (potential roles based on homology to related KCTD family members and emerging literature)Other (roles in protein degradation and signaling, but no well-established major disease associations unique to KCTD21)

Beyond the preview

Go deeper on Potassium channel tetramerization domain-containing protein 21 (KCTD21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel tetramerization domain-containing protein 21 (KCTD21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call